A Clinical Trial to Assess the Efficacy and Tolerance of a Berberine-based Nutraceutical Formula to Aid Blood Sugar Regulation and Metabolism

Conditions

• Metabolism Disorder
• Nutraceutical

Eligibility Criteria

Sex

ALL

Age

18 Years - 70 Years

Healthy Volunteers

Not accepted

Interventions

• Diaberine — DIETARY_SUPPLEMENT
  Participants will take one capsule three times daily, 15 minutes prior to meals, over a 24-week period.
• Placebo Capsule — DIETARY_SUPPLEMENT
  Participants will take one capsule three times daily, 15 minutes prior to meals, over a 24-week period.

Study Details

This randomized, triple-blind, placebo-controlled study will evaluate the efficacy of Diaberine, a berberine-based nutraceutical, in aiding blood sugar regulation and metabolism in 80 participants over 24 weeks.

Key Dates

Start date

Oct 3, 2024

Status verified

Dec 2024

Primary completion

May 1, 2025

Completion

May 1, 2025

Study Design

Enrollment

80 participants (estimated)

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Arms

• Experimental: Diaberine
  Participants in this arm will receive the Diaberine supplement, which contains Vitamin B12, berberine, magnesium citrate, water-extracted cinnamon bark (Cinnamomum cassia) at a 10:1 ratio, chromium (picolinate), rice flour, dicalcium phosphate, l-leucine, and HPMC (capsule).
• Placebo Comparator: Placebo
  Participants in this arm will receive a placebo capsule containing rice flour, dicalcium phosphate, l-leucine, and HPMC (capsule).

Primary Outcome Measure

Blood Sugar Regulation [ Time Frame: Baseline, Week 12, and Week 24 ]

Central Contacts

• Patrick Renner, MSc
  4242450284
  [email protected]

Locations (1)

Find similar trials in Santa Monica, CA

Related Studies

• Umbilical Cord Blood Transplantation From Unrelated Donors
  Recruiting · University of Rochester · Rochester, New York
• Metabolism Enhancement by Laser Therapy
  Not Yet Recruiting · Massachusetts General Hospital · Boston, Massachusetts